GHS-R1a constitutive activity and its physiological relevance

Frontiers in Neuroscience

Volumn , Issue 7 MAY, 2013, Pages

  Mear, Yves ^a   Enjalbert, Alain ^a,b   Thirion, Sylvie ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

^b HÔPITAL DE LA CONCEPTION   (France)

Author keywords

arrestin; Constitutive activity; Ghrelin receptor; GPCR; PLC; Signaling pathway

Indexed keywords

BETA ADRENERGIC RECEPTOR; BETA ARRESTIN 2; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; GHRELIN RECEPTOR; INOSITOL PHOSPHATE; PHOSPHOLIPASE C; PROTEIN KINASE C;

ARTICLE; BODY WEIGHT; CALCIUM MOBILIZATION; CARBOXY TERMINAL SEQUENCE; CELL MEMBRANE; CONSTITUTIVE ACTIVITY; ENDOCYTOSIS; ENDOSOME; ENERGY BALANCE; EXOCYTOSIS; HUMAN; INTERNALIZATION; LIGAND BINDING; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SERUM RESPONSIVE ELEMENT; SHORT STATURE; SIGNAL TRANSDUCTION; STRUCTURE ANALYSIS; UPREGULATION;

EID: 84878829975     PISSN: 16624548     EISSN: 1662453X     Source Type: Journal    
DOI: 10.3389/fnins.2013.00087     Document Type: Article

References (64)

1. Acunzo, J., Thirion, S., Roche, C., Saveanu, A., Gunz, G., Germanetti, A. L., et al. (2008). Somatostatin receptor sst2 decreases cell viability and hormonal hypersecretion and reverses octreotide resistance of human pituitary adenomas. Cancer Res. 68, 10163-10170.
2. Adams, E. F., Petersen, B., Lei, T., Buchfelder, M., and Fahlbusch, R. (1995). The growth hormone secretagogue, L-692, 429, induces phosphatidylinositol hydrolysis and hormone secretion by human pituitary tumors. Biochem. Biophys. Res. Commun. 208, 555-561.
3. Akamizu, T., and Kangawa, K. (2012). The physiological significance and potential clinical applications of ghrelin. Eur. J. Intern. Med. 23, 197-202.
4. Albarran-Zeckler, R. G., Brantley, A. F., and Smith, R. G. (2012). Growth hormone secretagogue receptor (GHS-R1a) knockout mice exhibit improved spatial memory and deficits in contextual memory. Behav. Brain Res. 232, 13-19.
5. Arvanitakis, L., Geras-Raaka, E., and Gershengorn, M. C. (1998). Constitutively signaling G-protein-coupled receptors and human disease. Trends Endocrinol. Metab. 9, 27-31.
6. Barlier, A., Zamora, A. J., Grino, M., Gunz, G., Pellegrini-Bouiller, I., Morange-Ramos, I., et al. (1999). Expression of functional growth hormone secretagogue receptors in human pituitary adenomas: polymerase chain reaction, triple in-situ hybridization and cell culture studies. J. Neuroendocrinol. 11, 491-502.
7. Bowers, C. Y., Sartor, A. O., Reynolds, G. A., and Badger, T. M. (1991). On the actions of the growth hormone-releasing hexapeptide, GHRP. Endocrinology 128, 2027-2035.
8. Camiña, J. P., Lodeiro, M., Ischenko, O., Martini, A. C., and Casanueva, F. F. (2007). Stimulation by ghrelin of p42/p44 mitogen-activated protein kinase through the GHS-R1a receptor: role of G-proteins and beta-arrestins. J. Cell. Physiol. 213, 187-200.
9. Castañeda, T. R., Tong, J., Datta, R., Culler, M., and Tschöp, M. H. (2010). Ghrelin in the regulation of body weight and metabolism. Front. Neuroendocrinol. 31, 44-60. doi: 10.1016/j.yfrne.2009.10.008
10. Chen, C., Wu, D., and Clarke, I. J. (1996). Signal transduction systems employed by synthetic GH-releasing peptides in somatotrophs. J. Endocrinol. 148, 381-386.
11. Cheng, K., Chan, W. W., Barreto, A., Convey, E. M., and Smith, R. G. (1989). The synergistic effects of His-D-Trp-Ala-Trp-D-Phe-Lys-NH2 on growth hormone (GH)-releasing factor-stimulated GH release and intracellular adenosine 3', 5'-monophosphate accumulation in rat primary pituitary cell culture. Endocrinology 124, 2791-2798.
12. Cheng, K., Chan, W. W., Butler, B., Barreto, A., and Smith, R. G. (1991). Evidence for a role of protein kinase-C in His-D-Trp-Ala-Trp-D-Phe-Lys-NH2-induced growth hormone release from rat primary pituitary cells. Endocrinology 129, 3337-3342.
13. Cruz, C. R. Y., and Smith, R. G. (2008). The growth hormone secretagogue receptor. Vitam. Horm. 77, 47-88.
14. Damian, M., Marie, J., Leyris, J. P., Fehrentz, J. A., Verdié, P., Martinez, J., et al. (2012). High constitutive activity is an intrinsic feature of ghrelin receptor protein: a study with a functional monomeric GHS-R1a receptor reconstituted in lipid discs. J. Biol. Chem. 287, 3630-3641.
15. Davis, J. F., Choi, D. L., Clegg, D. J., and Benoit, S. C. (2011). Signaling through the ghrelin receptor modulates hippocampal function and meal anticipation in mice. Physiol. Behav. 103, 39-43.
16. Elling, C. E., Thirstrup, K., Holst, B., and Schwartz, T. W. (1999). Conversion of agonist site to metal-ion chelator site in the beta(2)-adrenergic receptor. Proc. Natl. Acad. Sci. U.S.A. 96, 12322-12327.
17. Els, S., Schild, E., Petersen, P. S., Kilian, T. M., Mokrosinski, J., Frimurer, T. M., et al. (2012). An aromatic region to induce a switch between agonism and inverse agonism at the ghrelin receptor. J. Med. Chem. 55, 7437-7449.
18. Esposito, M., Pellinen, J., Kapás, L., and Szentirmai, É. (2012). Impaired wake-promoting mechanisms in ghrelin receptor-deficient mice. Eur. J. Neurosci. 35, 233-243.
19. Floquet, N., M'Kadmi, C., Perahia, D., Gagne, D., Bergé, G., Marie, J., et al. (2010). Activation of the ghrelin receptor is described by a privileged collective motion: a model for constitutive and agonist-induced activation of a sub-class A G-protein coupled receptor (GPCR). J. Mol. Biol. 395, 769-784.
20. Gozé, C., Bergé, G., M'Kadmi, C., Floquet, N., Gagne, D., Galleyrand, J. C., et al. (2010). Involvement of tryptophan W276 and of two surrounding amino acid residues in the high constitutive activity of the ghrelin receptor GHS-R1a. Eur. J. Pharmacol. 643, 153-161.
21. Herrington, J., and Hille, B. (1994). Growth hormone-releasing hexapeptide elevates intracellular calcium in rat somatotropes by two mechanisms. Endocrinology 135, 1100-1108.
22. Holliday, N. D., Holst, B., Rodionova, E. A., Schwartz, T. W., and Cox, H. M. (2007). Importance of constitutive activity and arrestin-independent mechanisms for intracellular trafficking of the ghrelin receptor. Mol. Endocrinol. 21, 3100-3112.
23. Holst, B., Cygankiewicz, A., Jensen, T. H., Ankersen, M., and Schwartz, T. W. (2003). High constitutive signaling of the ghrelin receptor-identification of a potent inverse agonist. Mol. Endocrinol. 17, 2201-2210.
24. Holst, B., Holliday, N. D., Bach, A., Elling, C. E., Cox, H. M., and Schwartz, T. W. (2004). Common structural basis for constitutive activity of the ghrelin receptor family. J. Biol. Chem. 279, 53806-53817.
25. Holst, B., Lang, M., Brandt, E., Bach, A., Howard, A., Frimurer, T. M., et al. (2006). Ghrelin receptor inverse agonists: identification of an active peptide core and its interaction epitopes on the receptor. Mol. Pharmacol. 70, 936-946.
26. Holst, B., Mokrosinski, J., Lang, M., Brandt, E., Nygaard, R., Frimurer, T. M., et al. (2007). Identification of an efficacy switch region in the ghrelin receptor responsible for interchange between agonism and inverse agonism. J. Biol. Chem. 282, 15799-15811.
27. Holst, B., and Schwartz, T. W. (2006). Ghrelin receptor mutations-too little height and too much hunger. J. Clin. Invest. 116, 637-641.
28. Howard, A. D., Feighner, S. D., Cully, D. F., Arena, J. P., Liberator, P. A., Rosenblum, C. I., et al. (1996). A receptor in pituitary and hypothalamus that functions in growth hormone release. Science 273, 974-977.
29. Inoue, H., Kangawa, N., Kinouchi, A., Sakamoto, Y., Kimura, C., Horikawa, R., et al. (2011). Identification and functional analysis of novel human growth hormone secretagogue receptor (GHSR) gene mutations in Japanese subjects with short stature. J. Clin. Endocrinol. Metab. 96, E373-E378.
30. Jiang, H., Betancourt, L., and Smith, R. G. (2006). Ghrelin amplifies dopamine signaling by cross talk involving formation of growth hormone secretagogue receptor/dopamine receptor subtype 1 heterodimers. Mol. Endocrinol. 20, 1772-1785.
31. Kern, A., Albarran-Zeckler, R., Walsh, H. E., and Smith, R. G. (2012). Apo-ghrelin receptor forms heteromers with DRD2 in hypothalamic neurons and is essential for anorexigenic effects of DRD2 agonism. Neuron 73, 317-332.
32. Kojima, M., Hosoda, H., Date, Y., Nakazato, M., Matsuo, H., and Kangawa, K. (1999). Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402, 656-660.
33. Kojima, M., Hosoda, H., Matsuo, H., and Kangawa, K. (2001). Ghrelin: discovery of the natural endogenous ligand for the growth hormone secretagogue receptor. Trends Endocrinol. Metab. 12, 118-122.
34. Korbonits, M., Jacobs, R. A., Aylwin, S. J., Burrin, J. M., Dahia, P. L., Monson, J. P., et al. (1998). Expression of the growth hormone secretagogue receptor in pituitary adenomas and other neuroendocrine tumors. J. Clin. Endocrinol. Metab. 83, 3624-3630.
35. Lau, P. N., Chow, K. B. S., Chan, C. B., Cheng, C. H. K., and Wise, H. (2009). The constitutive activity of the ghrelin receptor attenuates apoptosis via a protein kinase C-dependent pathway. Mol. Cell. Endocrinol. 299, 232-239.
36. Lefkowitz, R. J. (1998). G Protein-coupled Receptors. J. Biol. Chem. 273, 18677-18680.
37. Lei, T., Buchfelder, M., Fahlbusch, R., and Adams, E. F. (1995). Growth hormone releasing peptide (GHRP-6) stimulates phosphatidylinositol (PI) turnover in human pituitary somatotroph cells. J. Mol. Endocrinol. 14, 135-138.
38. Lodeiro, M., Theodoropoulou, M., Pardo, M., Casanueva, F. F., and Camiña, J. P. (2009). c-Src regulates Akt signaling in response to ghrelin via beta-arrestin signaling-independent and -dependent mechanisms. PLoS ONE 4:e4686. doi: 10.1371/journal.pone.0004686
39. Mary, S., Damian, M., Louet, M., Floquet, N., Fehrentz, J., Marie, J., et al. (2012). Ligands and signaling proteins govern the conformational landscape explored by a G protein-coupled receptor. Proc. Natl. Acad. Sci. U.S.A. 109, 8304-8309.
40. Matthews, R. P., Guthrie, C. R., Wailes, L. M., Zhao, X., Means, A. R., and McKnight, G. S. (1994). Calcium/calmodulin-dependent protein kinase types II and IV differentially regulate CREB-dependent gene expression. Mol. Cell. Biol. 14, 6107-6116.
41. Mokrosinski, J., Frimurer, T. M., Sivertsen, B., Schwartz, T. W., and Holst, B. (2012). Modulation of constitutive activity and signaling bias of the ghrelin receptor by conformational constraint in the second extracellular loop. J. Biol. Chem. 287, 33488-33502.
42. Mokrosinski, J., and Holst, B. (2010). Modulation of the constitutive activity of the ghrelin receptor by use of pharmacological tools and mutagenesis. Methods Enzymol. 484, 53-73.
43. Pantel, J., Legendre, M., Cabrol, S., Hilal, L., Hajaji, Y., Nivot, S., et al. (2006). Loss of constitutive activity of the growth hormone secretagogue receptor in familial short stature. J. Clin. Invest. 116, 760-768.
44. Pantel, J., Legendre, M., Nivot, S., Morisset, S., Vie-Luton, M. P., Le Bouc, Y., et al. (2009). Recessive isolated growth hormone deficiency and mutations in the ghrelin receptor. J. Clin. Endocrinol. Metab. 94, 4334-4341.
45. Park, S., Jiang, H., Zhang, H., and Smith, R. G. (2012). Modification of ghrelin receptor signaling by somatostatin receptor-5 regulates insulin release. Proc. Natl. Acad. Sci. U.S.A. 109, 19003-19008.
46. Petersen, P. S., Woldbye, D. P. D., Madsen, A. N., Egerod, K. L., Jin, C., Lang, M., et al. (2009). In vivo characterization of high Basal signaling from the ghrelin receptor. Endocrinology 150, 4920-4930.
47. Petersenn, S. (2002). Structure and regulation of the growth hormone secretagogue receptor. Minerva Endocrinol. 27, 243-256.
48. Pong, S. S., Chaung, L. Y., Dean, D. C., Nargund, R. P., Patchett, A. A., and Smith, R. G. (1996). Identification of a new G-protein-linked receptor for growth hormone secretagogues. Mol. Endocrinol. 10, 57-61.
49. Portelli, J., Thielemans, L., Ver Donck, L., Loyens, E., Coppens, J., Aourz, N., et al. (2012). Inactivation of the constitutively active ghrelin receptor attenuates limbic seizure activity in rodents. Neurotherapeutics 9, 658-672.
50. Poulin, B., Maccario, H., Thirion, S., Junoy, B., Boyer, B., Enjalbert, A., et al. (2009). Ubiquitination as a priming process of PKC alpha and PKC epsilon degradation in the alphaT3-1 gonadotrope cell line. Neuroendocrinology 89, 252-266.
51. Rediger, A., Piechowski, C. L., Habegger, K., Grüters, A., Krude, H., Tschöp, M. H., et al. (2012). MC4R dimerization in the paraventricular nucleus and GHSR/MC3R heterodimerization in the arcuate nucleus: is there relevance for body weight regulation?. Neuroendocrinology 95, 277-288.
52. Rediger, A., Piechowski, C. L., Yi, C. X., Tarnow, P., Strotmann, R., Grüters, A., et al. (2011). Mutually opposite signal modulation by hypothalamic heterodimerization of ghrelin and melanocortin-3 receptors. J. Biol. Chem. 286, 39623-39631.
53. Reiter, E., Ahn, S., Shukla, A. K., and Lefkowitz, R. J. (2012). Molecular mechanism of β-arrestin-biased agonism at seven-transmembrane receptors. Annu. Rev. Pharmacol. Toxicol. 52, 179-197.
54. Roche, C., Rasolonjanahary, R., Thirion, S., Goddard, I., Fusco, A., Figarella-Branger, D., et al. (2012). Inactivation of transcription factor pit-1 to target tumoral somatolactotroph cells. Hum. Gene Ther. 23, 104-114.
55. Schellekens, H., Van Oeffelen, W. E., Dinan, T. G., and Cryan, J. F. (2013). Promiscuous dimerization of the growth hormone secretagogue receptor (GHS-R1a) attenuates ghrelin-mediated signaling. J. Biol. Chem. 288, 181-191.
56. Schwartz, T. W., Frimurer, T. M., Holst, B., Rosenkilde, M. M., and Elling, C. E. (2006). Molecular mechanism of 7TM receptor activation-a global toggle switch model. Annu. Rev. Pharmacol. Toxicol. 46, 481-519.
57. Seachrist, J. L., and Ferguson, S. S. (2003). Regulation of G protein-coupled receptor endocytosis and trafficking by Rab GTPases. Life Sci. 74, 225-235.
58. Seifert, R., and Wenzel-Seifert, K. (2002). Constitutive activity of G-protein-coupled receptors: cause of disease and common property of wild-type receptors. Arch. Pharmacol. 366, 381-416.
59. Shukla, A. K., Xiao, K., and Lefkowitz, R. J. (2011). Emerging paradigms of β-arrestin-dependent seven transmembrane receptor signaling. Trends Biochem. Sci. 36, 457-469.
60. Sivertsen, B., Lang, M., Frimurer, T. M., Holliday, N. D., Bach, A., Els, S., et al. (2011). Unique interaction pattern for a functionally biased ghrelin receptor agonist. J. Biol. Chem. 286, 20845-20860.
61. Smit, M. J., Vischer, H. F., Bakker, R. A., Jongejan, A., Timmerman, H., Pardo, L., et al. (2007). Pharmacogenomic and structural analysis of constitutive g protein-coupled receptor activity. Annu. Rev. Pharmacol. Toxicol. 47, 53-87.
62. Stengel, A., and Taché, Y. (2012). Ghrelin-a pleiotropic hormone secreted from endocrine x/a-like cells of the stomach. Front. Neurosci. 6:24. doi: 10.3389/fnins.2012.00024
63. Valentin-Hansen, L., Holst, B., Frimurer, T. M., and Schwartz, T. W. (2012). PheVI:09 (Phe6.44) as a sliding microswitch in seven-transmembrane (7TM) G protein-coupled receptor activation. J. Biol. Chem. 287, 43516-43526.
64. Wang, H. J. (2004). Ghrelin receptor gene: identification of several sequence variants in extremely obese children and adolescents, healthy normal-weight and underweight students, and children with short normal stature. J. Clin. Endocrinol. Metab. 89, 157-162.